This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK) | MicrobiomeTrials
← Back to trials NCT04201964
Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK) Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2019-12-15Est. Completion: 2028-06-30
Enrollment target: 30 participantsLocations General Hospital of Northern Theater Command, Shenyang, China Other microbiome trials you might be interested in Ischemic Stroke Small Vessel Cerebrovascular Disease Cholesterol, LDL Secondary Prevention Cardiovascular Diseases
Lipid-lowering therapy constitutes a cornerstone of secondary prevention in ischemic stroke; however, current stroke gui…
Ansan, South Korea Est. completion Sep 2030
Nonvalvular Atrial Fibrillation
This prospective, open-label, multicenter randomized controlled trial will compare two preprocedural imaging assessment …
Shanghai, China Est. completion Sep 1, 2028